# 5-Amino-1MQ vs Semaglutide: How They Differ | PepVault

Source: https://pepvault.app/peptides/compare/5-amino-1mq-vs-semaglutide

Last updated: 2026-09-26

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Library](https://pepvault.app/peptides) [Comparisons](https://pepvault.app/peptides/compare) 5-Amino-1MQ vs Semaglutide

Compared side by side

# 5-Amino-1MQ vs semaglutide: how they differ

Reviewed September 2026 [How we check the library](https://pepvault.app/about#library) [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The short answer

Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows stomach emptying; 5-Amino-1MQ is a small molecule (not a peptide) that blocks the NNMT enzyme in fat cells, and in obese mice it cut weight and fat without reducing food intake. Semaglutide is FDA-approved, with about 15% average weight loss at 68 weeks in its main trial, and 5-Amino-1MQ has no human studies. Commonly reported: “food noise” going quiet on semaglutide, and nothing to feel on 5-Amino-1MQ, though some describe easier fat loss alongside a deficit or a GLP-1.

## Side by side

| Compared | [5-Amino-1MQ](https://pepvault.app/peptides/5-amino-1mq) | [Semaglutide](https://pepvault.app/peptides/semaglutide) |
| --- | --- | --- |
| Category | Metabolic & GLP-1 | Metabolic & GLP-1 |
| Also known as | 5-A-1MQ, 5Amino1MQ, 5-Amino-1-methylquinolinium | Ozempic, Wegovy |
| What it is | A small molecule (not a peptide) that blocks the NNMT enzyme in fat cells, which raises NAD+ and pushes fat cells toward burning energy. | A GLP-1 receptor agonist that mimics a gut hormone your body releases after eating: it reduces appetite and slows stomach emptying. |
| How it works | NNMT (Nicotinamide N-methyltransferase) inhibitor that blocks NNMT activity in fat cells. In cultured fat cells it raises NAD+ and SAM levels; in obese mice it cut body weight and fat without reducing food intake, and with a reduced-calorie diet lean mass made up a larger share of body weight. No human data. | GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and improves glucose metabolism. FDA-approved for T2DM and obesity. Titrate dose slowly to minimize GI side effects. |
| Commonly reported | Nothing to feel, though some describe easier fat loss alongside a deficit or a GLP-1. There are no human studies, and the mouse work used injections rather than oral doses. | The constant background thoughts about food ("food noise") go quiet and portions shrink without effort, with nausea worst in the first days after each dose step. FDA-approved for type 2 diabetes, weight management, heart-risk reduction and MASH, with about 15% average weight loss at 68 weeks in its main trial. |
| Studied range | Research range: 50–100 mg. Studied in research — not a recommendation. | FDA label: 0.25–2.4 mg, starting dose 0.25 mg. |
| How often | Daily | Weekly SubQ |
| Half-life | Unknown | ~1 week (FDA label) |
| Route | Oral | SubQ injection |
| Typical run | Very limited data. Some run 8–12 weeks then cycle off. Preclinical compound — approach conservatively. | FDA-approved for ongoing use. Community uses indefinitely or until goal weight reached, then tapers. |
| Evidence | Emerging: primarily preclinical / limited human data | Established: clinical trials or FDA-approved use exists |
| Common side effects | Limited human data, generally well tolerated in early research | Nausea, vomiting, diarrhea, constipation, decreased appetite, fatigue, pancreatitis risk |

Typical run: Community practice — opinions vary. Not a clinical recommendation.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking 5-Amino-1MQ or semaglutide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Week by week

Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.

### 5-Amino-1MQ

- Day 1–28 Quiet compound, slow signal
- Day 28–84 Recomp in a deficit
- Day 84–168 Cycle decision point

[Every card for 5-Amino-1MQ, with its sources](https://pepvault.app/peptides/5-amino-1mq#weeks)

### Semaglutide

- Day 1–28 · 0.25 mg Gut is adapting
- Day 29–56 · 0.5 mg Appetite shifts are real now
- Day 57–112 · 1 mg Clinically useful weight loss kicks in
- Day 113–140 · 1.7 mg Max submaximal step
- Day 141–364 · 2.4 mg Full dose — the working dose
- Day 365+ Plateau territory — new baseline

[Every card for semaglutide, with its sources](https://pepvault.app/peptides/semaglutide#weeks)

## Together or one or the other

5-Amino-1MQ and semaglutide are a common stack: 5-Amino-1MQ lists semaglutide among its common stacks.

Community · 5-Amino-1MQ

### Layered onto a GLP-1 cut

Common community pattern: 5-Amino-1MQ layered onto an ongoing GLP-1 protocol. The GLP-1 drives the calorie deficit while 5-Amino-1MQ helps protect lean mass from the fat-cell side (a mouse finding). Commonly reported: some find recomposition a bit easier; others notice no change.

## With this comparison

### 5-Amino-1MQ

- [5-Amino-1MQ: the full reference](https://pepvault.app/peptides/5-amino-1mq)
- [5-Amino-1MQ dose guide](https://pepvault.app/lab/dosage/5-amino-1mq)

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [5-Amino-1MQ slowed bladder tumor growth in mice](https://pepvault.app/research/5-amino-1mq-yang-2024)
- [5-Amino-1MQ plus low-fat diet gave obese mice a distinct microbiome](https://pepvault.app/research/5-amino-1mq-dimet-wiley-2022)
- [5-Amino-1MQ slowed growth of HeLa cervical cancer cells in the lab](https://pepvault.app/research/5-amino-1mq-akar-2021)
- [All 3 studies](https://pepvault.app/research#5-amino-1mq)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [Semaglutide (oral): smaller HbA1c drop than orforglipron in ACHIEVE-3](https://pepvault.app/research/semaglutide-achieve-3-2026)
- [Semaglutide (oral) did not slow early Alzheimer's in evoke trials](https://pepvault.app/research/semaglutide-oral-evoke-and-evoke-2026)
- [All 20 studies](https://pepvault.app/research#semaglutide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Receptor agonist](https://pepvault.app/glossary/receptor-agonist)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Cycle](https://pepvault.app/glossary/cycle)
- [Stack](https://pepvault.app/glossary/stack)
- [GLP-1](https://pepvault.app/glossary/glp-1)

## Questions people ask

### How long do 5-Amino-1MQ and semaglutide last?

The half-life of 5-Amino-1MQ is unknown. The half-life of semaglutide is ~1 week (FDA label).

### How often are 5-Amino-1MQ and semaglutide taken?

5-Amino-1MQ: daily. Route: Oral. Semaglutide: weekly SubQ. Route: SubQ injection.

### How are 5-Amino-1MQ and semaglutide dosed in research?

The research range for 5-Amino-1MQ is 50–100 mg. Studied in research — not a recommendation. The FDA label range for semaglutide is 0.25–2.4 mg, with a 0.25 mg starting dose.

### What are the common side effects of 5-Amino-1MQ and semaglutide?

For 5-Amino-1MQ, the library lists: limited human data, generally well tolerated in early research. For semaglutide: nausea, vomiting, diarrhea, constipation, decreased appetite, fatigue, pancreatitis risk.

### Are 5-Amino-1MQ and semaglutide taken together?

5-Amino-1MQ and semaglutide are a common stack: 5-Amino-1MQ lists semaglutide among its common stacks. Common community pattern: 5-Amino-1MQ layered onto an ongoing GLP-1 protocol. The GLP-1 drives the calorie deficit while 5-Amino-1MQ helps protect lean mass from the fat-cell side (a mouse finding). Commonly reported: some find recomposition a bit easier; others notice no change.

## Each one in full

- [5-Amino-1MQ: dosage, half-life & reference guide](https://pepvault.app/peptides/5-amino-1mq)
- [Semaglutide: dosage, half-life & reference guide](https://pepvault.app/peptides/semaglutide)
- [5-Amino-1MQ dose guide](https://pepvault.app/lab/dosage/5-amino-1mq)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking 5-Amino-1MQ or semaglutide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking 5-Amino-1MQ or semaglutide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this comparison

### 5-Amino-1MQ

- [5-Amino-1MQ: the full reference](https://pepvault.app/peptides/5-amino-1mq)
- [5-Amino-1MQ dose guide](https://pepvault.app/lab/dosage/5-amino-1mq)

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [5-Amino-1MQ slowed bladder tumor growth in mice](https://pepvault.app/research/5-amino-1mq-yang-2024)
- [5-Amino-1MQ plus low-fat diet gave obese mice a distinct microbiome](https://pepvault.app/research/5-amino-1mq-dimet-wiley-2022)
- [5-Amino-1MQ slowed growth of HeLa cervical cancer cells in the lab](https://pepvault.app/research/5-amino-1mq-akar-2021)
- [All 3 studies](https://pepvault.app/research#5-amino-1mq)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [Semaglutide (oral): smaller HbA1c drop than orforglipron in ACHIEVE-3](https://pepvault.app/research/semaglutide-achieve-3-2026)
- [Semaglutide (oral) did not slow early Alzheimer's in evoke trials](https://pepvault.app/research/semaglutide-oral-evoke-and-evoke-2026)
- [All 20 studies](https://pepvault.app/research#semaglutide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Receptor agonist](https://pepvault.app/glossary/receptor-agonist)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Cycle](https://pepvault.app/glossary/cycle)
- [Stack](https://pepvault.app/glossary/stack)
- [GLP-1](https://pepvault.app/glossary/glp-1)

<!--promo-->

PepVault for iPhone

## Taking 5-Amino-1MQ or semaglutide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## More comparisons

- [All peptide comparisons](https://pepvault.app/peptides/compare)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

## The library

- [The peptide reference library](https://pepvault.app/peptides)
- [Metabolic & GLP-1 peptides](https://pepvault.app/peptides#metabolic)

## Free tools

- [The Dose Guide](https://pepvault.app/lab/dosage)
- [Half-life & active level](https://pepvault.app/tools/peptide-half-life-calculator)
- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it. Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, Victoza and Trulicity are trademarks of their respective owners; PepVault is independent and not affiliated with or endorsed by any manufacturer.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
